Ablaze Pharmaceuticals
Latest round
- Series A
Last raised
- Nov 2021
Total raised
- $75M
Investors
- 8
About Ablaze Pharmaceuticals
Established in 2021 and based in Shanghai, China, Ablaze Pharmaceuticals is a biopharmaceutical company that focuses on research and development of radiotherapy drugs and Targeted Radiotherapy (TRT). The president and CEO Dr. Alex Qiao is the postdoctoral in biochemistry at the Massachusetts Institute of Technology, he co-founded and was CEO of NajingTech from 2008 to 2012 and has over 20 years of experience as an entrepreneur, business leader and technology innovator in the life sciences, biopharmaceutical and high-tech industries. The company is main business is research and development of radiotherapy drugs and Targeted Radiotherapy (TRT), technology development, technology consulting, technology service, technology transfer in the fields of medical technology and biotechnology, and wholesale and retail of first-class medical equipment.
Who invested in Ablaze Pharmaceuticals
8 investors across 1 round
See all investors in Ablaze Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Nov 29, 2021
Amount
$75M
Investors
Questions about Ablaze Pharmaceuticals
Who invested in Ablaze Pharmaceuticals?
Ablaze Pharmaceuticals has 8 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Ablaze Pharmaceuticals raised?
Ablaze Pharmaceuticals has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Ablaze Pharmaceuticals last raise money?
Ablaze Pharmaceuticals's most recent round on record is a Series A, in Nov 2021.
What does Ablaze Pharmaceuticals do?
Established in 2021 and based in Shanghai, China, Ablaze Pharmaceuticals is a biopharmaceutical company that focuses on research and development of radiotherapy drugs and Targeted Radiotherapy (TRT).
Where is Ablaze Pharmaceuticals headquartered?
Ablaze Pharmaceuticals is headquartered in Shanghai, China.
Which VCs invest in companies like Ablaze Pharmaceuticals?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Ablaze Pharmaceuticals's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Ablaze Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.